Non-small cell lung cancer treatment (r)evolution: ten years of advances and more to come

Diagnostic and treatment algorithms in non-small cell lung cancer (NSCLC) are evolving at a never-before-seen pace. Histological subtyping to maximise treatment efficacy and avoid toxicity has marked the beginning of the revolution, opening the way to molecular characterisation to guide genomically...

Descripción completa

Detalles Bibliográficos
Autores principales: Toschi, Luca, Rossi, Sabrina, Finocchiaro, Giovanna, Santoro, Armando
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cancer Intelligence 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5718252/
https://www.ncbi.nlm.nih.gov/pubmed/29225694
http://dx.doi.org/10.3332/ecancer.2017.787

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5718252/
https://www.ncbi.nlm.nih.gov/pubmed/29225694
http://dx.doi.org/10.3332/ecancer.2017.787

Ejemplares similares